TAM
PRCT icon

Thematics Asset Management’s Procept Biorobotics PRCT Stock Holding History

Thematics Asset Management’s Portfolio PRCT Stock Details PRCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$22.5M Buy
630,053
+235,344
+60% +$10.7M 1.02% 37
2025
Q2 		$22.7M Buy
394,709
+168,453
+74% +$9.52M 1.02% 36
2025
Q1 		$13.2M Buy
226,256
+225,680
+39,181% +$15.4M 0.67% 56
2024
Q4 		$46.4K Buy
+576
New +$49.2K ﹤0.01% 135

Other funds holding PRCT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
CC
Chicago Capital Chicago, Illinois $3.71B AUM 19.51% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Thematics Asset Management's PRCT Position: Q3 2025 in Review

Thematics Asset Management increased its Procept Biorobotics (PRCT) stake by 60% in Q3 2025, buying an estimated $10.7M and bringing the position to 630,053 shares worth $22.5M. The position accounts for 1.02% of the portfolio, ranked #37.

Thematics Asset Management first reported a position in PRCT in Q4 2024 and has held it in 4 quarters since. The position peaked at $22.7M in Q2 2025. 242 funds tracked by Wall St. Rank hold PRCT as of Q3 2025.

  • Thematics Asset Management held 630,053 shares of Procept Biorobotics worth $22.5M as of Q3 2025.
  • Thematics Asset Management bought 235,344 Procept Biorobotics shares in Q3 2025, an estimated $10.7M.
  • Procept Biorobotics made up 1.02% of Thematics Asset Management's portfolio in Q3 2025, its #37 holding.
  • Thematics Asset Management first reported a position in Procept Biorobotics in Q4 2024 and has held it in 4 quarters since.
  • Thematics Asset Management's Procept Biorobotics position peaked at $22.7M in Q2 2025.
  • 242 funds tracked by Wall St. Rank held Procept Biorobotics as of Q3 2025.

Based on Thematics Asset Management's 13F filing for Q3 2025, filed 14 Nov 2025.